Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Mandonnet, E; Wager, M; Almairac, F; Baron, MH; Blonski, M; Freyschlag, CF; Barone, F; Fontaine, D; Pallud, J; Hegi, M; Viegas, C; Zetterling, M; Spena, G; Goodden, J; Rutten, GJ; Taillandier, L; Foroglu, N; Darlix, A; Skrap, M; Martino, J; von Campe, G; Madadaki, C; Gayat, E; de Witt Hamer, P; Gil Robles, S; Sarubbo, S; Santarius, T; Bello, L; Forster, MT; Duffau, H.
Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?
Neurooncol Pract. 2017; 4(4):241-247 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
von Campe Gord

Dimensions Citations:

Plum Analytics:
Number of Figures: 2
| |
Diffuse low-grade glioma form a rare entity affecting young people. Despite advances in surgery, chemotherapy, and radiation therapy, diffuse low-grade glioma are still incurable. According to current guidelines, maximum safe resection, when feasible, is the first line of treatment. Apart from surgery, all other treatment modalities (temozolomide, procarbazine-CCNU-vincristine regimen, and radiation therapy) are handled very differently among different teams, and this in spite of recent results of several phase 3 studies. Based on a European survey, this paper aimed to get a picture of this heterogeneity in diffuse low-grade glioma management, to identify clinically relevant questions raised by this heterogeneity of practice, and to propose new methodological frameworks to address these questions.

Find related publications in this database (Keywords)
diffuse low-grade glioma
evidence-based medicine
© Med Uni Graz Impressum